Navigation Links
Watson Acquires Uteron Pharma SA
Date:1/23/2013

ate
Currently in end of Phase II clinical studies, the Estelle contraceptive product is being developed for global markets, with anticipated launch in 2018.  Estelle contains a novel natural estrogen, estetrol, which the Company believes will provide a prolonged half-life, a higher safety margin, less interference with liver and metabolic functions and an improved side effect profile.  Estelle is being studied in combination with a progestin and will be marketed in a convenient dosing regimen.  The product has patent protection until 2025 in the U.S. and 2027 in the E.U.

Early Stage Development Opportunities
As part of the acquisition, Watson acquires multiple potential products in early stage development; including Vaginate, being developed for the potential treatment of vaginal infections, Colvir, which is being studied for the treatment of premalignant Human Papilloma Virus (HPV) lesions of the uterine cervix and other product opportunities in Women's Health.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. (NYSE: WPI) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.  The Company has global and U.S. headquarters in Parsippany, New Jersey, USA, and international headquarters in Zug, Switzerland. 

Watson is the world's third-largest generics pharmaceutical manufacturer, with more than 750 products marketed globally through operations in more than 60 countries.  Watson's global branded pharmaceutical business develops and markets products principally in Urology and Women's Health, and is committed to developing and marketing biosimilars products in Women's Health, Oncology and other therapeutic categories.  In addition, Watson is the fourth-largest U.S. generic pharmaceutical
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Watson to Present at the 2012 Piper Jaffray Health Care Conference
2. Watson to Present at the 2012 Annual Credit Suisse Healthcare Conference
3. Watson Third Quarter 2012 Non-GAAP Diluted EPS Increases 24% to $1.35; Net Revenue Increases 19% to $1.29 Billion
4. Watson Announces Global Generics Management Team
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Cleveland Clinic and IBM Work to Advance Watsons Use in the Medical Training Field
7. Watson Announces Sale of Rugby OTC Product Trademark and Assets to Major Pharmaceuticals, a division of The Harvard Drug Group, LLC
8. Watson to Present at the 2012 Bank of America Merrill Lynch Global Healthcare Conference
9. Watson to Present at the Morgan Stanley 2012 Global Healthcare Conference
10. Watson Applauds GPhA Study Demonstrating $1 Trillion in Prescription Drug Savings from Generic Medicines
11. Watson and Actavis Receive FTC Second Request
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015   The New York Times ... internationally acclaimed plastic surgeon, Dr. Rod Rohrich . ... is proven to reduce fat deposits under the chin. ... The active ingredient in Kybella, deoxycholic acid, dissolves ... the ability to reshape this area without surgery. "So ...
(Date:5/4/2015)... , May 4, 2015 Former NASA ... News online last week where he discussed Theradome™, the ... be FDA-cleared. The FOX segment shows firsthand how, via ... affordable hair loss solution that will not require surgery ... the mitochondria at the base of the hair follicle, ...
(Date:5/4/2015)... Conn. , May 4, 2015 /PRNewswire/ ... market private equity firm, announced today that ... portfolio company, BioPharm Communications. BioPharm specializes in the ... programs for the pharmaceutical and biotechnology industries. ... repaid to its shareholders half of their ...
Breaking Medicine Technology:Dr. Rod Rohrich Provides Medical Expertise on Kybella 2Dr. Rod Rohrich Provides Medical Expertise on Kybella 3FOX News Features Theradome as the Take-Home Solution to Tackle Baldness 2Southfield Capital and BioPharm Communications Announce Dividend Recapitalization 2
... , ST. LOUIS , ... today announced that it will broadcast its fourth quarter earnings results ... Thursday, February 4, 2010 at 11:00 a.m. Central Time ... through InterCall at http://tinyurl.com/yi4q09 .  Access to the live audio ...
... , RICHMOND, Calif. , Jan. 27 ... the company will release its fourth quarter and full year 2009 financial ... The press release will be followed by a conference call at ... telephone and webcast. During the conference call, the company will review the ...
Cached Medicine Technology:Young Innovations, Inc. Provides 4th Quarter Conference Call Details 2Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast 2
(Date:5/4/2015)... The American Telemedicine Association (ATA) today released an update ... in coverage and reimbursement, and physician practice standards and ... Reports last September, many state regulating bodies responded by ... delivery in their state,” said Jonathan Linkous, CEO of ... nation, ATA reevaluated the indicators for each state and ...
(Date:5/4/2015)... 2015 METTLER TOLEDO has announced ... Data Integrity in a GXP Regulated Laboratory ", ... This webinar will be presented on May 27, ... integrity is a critical component of pharmaceutical product ... However, in recent years an increasing number of ...
(Date:5/4/2015)... Washington, DC (PRWEB) May 04, 2015 ... of Kit Check as a finalist for the EY ... Washington Region. The awards program recognizes entrepreneurs who ... innovation, financial performance and personal commitment to their businesses ... finalist by a panel of independent judges. Award ...
(Date:5/4/2015)... Ticket Down is a reputable source for authentic ... in Columbia, South Carolina. Fans of Paul McCartney have ... tour which originally kicked off in 2013. The most visited ... the legendary performer recently announced that he would be adding ... June 21st, in Charlottesville, VA at John Paul Jones Arena ...
(Date:5/4/2015)... San Diego, CA (PRWEB) May 04, 2015 ... hosted a ribbon cutting ceremony at their brand new, ... of this year. The new building will not only ... patient population, but will also offer community and educational ... , The new facility is located next door to ...
Breaking Medicine News(10 mins):Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 3Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2Health News:EY announces Kit Check CEO and Co-founder Kevin MacDonald as an EY Entrepreneur Of The Year® 2015 Award finalist in the Greater Washington Region 2Health News:Paul McCartney Tickets at Colonial Life Arena in Columbia, SC: Ticket Down Slashes Paul McCartney Ticket Prices in Columbia, South Carolina at Colonial Life Arena 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3
... Oct. 28 A few spaces remain for the ... Symposium on Nov. 4-5, 2009. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ... writers and journalists and will focus on how FDA ... , This year,s symposium will feature an address by ...
... 28 If we get a boo-boo, we might know to ... kiss it and make it all better. But, what if ... us who aren,t prepared for dental emergencies can quickly get back ... Company at: , http://inr.mediaseed.tv/oneClip_C/?feed=Ss8P5Rb1iQulYDAELUR0M_kpwKp_6YSM , Medialink ...
... Oct. 28 Collagen Matrix, Inc., the leader in ... Shu-Tung Li, the Company,s Founder, President, and Chief Executive ... Executive of the Year category of the 2009 New ... Politziner and Mattia, Certified Public Accountants and Consultants. ...
... Inc . (Pink Sheets: JEDM) ( www.jedimindinc.com ) ... excellent cash position to expand both the gaming and medical divisions ... in excess of $500,000 of working capital which is being used ... computer hardware and software applications to the latest standards. , ...
... Research Foundation (LRF) is pleased to announce that David ... Thomas Kipps, MD, PhD, Moores Cancer Center, University of ... round of funding under the Foundation,s Chronic Lymphocytic Leukemia ... Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) are ...
... and mental health in study , WEDNESDAY, Oct. 28 ... the emotional and mental well-being of breast cancer patients, ... 130 patients at Saint Joseph Hospital in Chicago, aged ... meditation group or to a usual care control group. ...
Cached Medicine News:Health News:Shu-Tung Li, Founder and CEO of Collagen Matrix, Inc. Honored as 2009 New Jersey Executive of the Year Finalist and Company Named One of Fifty Fastest Growing Companies 2Health News:Jedi Mind, Inc. in Excellent Financial Shape to Expand Business 2Health News:Lymphoma Research Foundation announces recipients of CLL/SLL Research Initiative grants 2Health News:Meditation May Reduce Stress in Breast Cancer Patients 2
... an integral part of the enzymatic cascade ... as well as the degradation of Bradykinin. ... is primarily located in endothelial cells. ACE ... for sarcoidosis and myocardial infarction but is ...
... and quantitative evaluation of pancreatic b-cell function is ... post-diagnostic study of the natural history of diabetes ... as a guide to the correct choice of ... to assess b-cell function because of the ...
... hormone responsible for the control of glucose metabolism. ... the islets of Langerhans as the precursor, proinsulin, ... Both are secreted in equimolar amounts into ... is comprised of two polypeptide chains, the A-chain ...
... quantitative evaluation of pancreatic -cell function is not ... study of the natural history of diabetes mellitus, ... a guide to the correct choice of treatment. ... -cell function because of the large and variable ...
Medicine Products: